Positive correlation between SIRPγlow T-cells and proinflammatory effector molecules from T-cells of RRMS and T1D patients suggest that reduced SIRPγ expression on T-cells could potentiate target organ-specific inflammation in autoimmunity. Here, SIRPG is linked to Autoimmunity.